Overview
The [Lys(Me3)12]-Histone H4(1-21)-GGK(Biotin) is a specialized peptide designed for advanced research applications involving protein interactions and epigenetic studies. This peptide consists of amino acid residues 1 to 21 of histone H4, featuring a unique combination of chemical modifications that enhance its functionality in various assays.
Key Features
- Acetylated N-terminus for enhanced stability
- Trimethylated at Lys-12 to mimic natural histone modifications
- C-terminal GG linker for effective conjugation
- Biotinylated lysine for strong binding capabilities in detection assays
- Supplied at >95% peptide purity, ensuring reliable results
Specifications
| Product Name | [Lys(Me3)12]-Histone H4(1-21)-GGK(Biotin) |
| Purity | >95% |
| Weight | 1 mg |
| Solubility | 1 mg/ml in distilled water |
FAQ
What applications can I use this peptide for?
This peptide is ideal for research applications focused on histone modifications, protein interactions, and epigenetic regulation. It can be utilized in various assays, including immunoprecipitation and Western blotting.
How should I store the peptide?
Store the [Lys(Me3)12]-Histone H4(1-21)-GGK(Biotin) peptide at -20°C for long-term preservation. It’s important to keep it away from moisture and light to maintain its stability.
Can I use this peptide in combination with other substrates?
Yes, this peptide can be effectively combined with other substrates, such as those available in our catalog like PKG Substrate RKRSRAE and Autocamtide-2 KKALRRQETVDALto enhance your experimental results.
This peptide is a reliable tool for researchers needing precise and effective histone modifications. You can purchase the [Lys(Me3)12]-Histone H4(1-21)-GGK(Biotin) peptide today and take advantage of its unique properties to further your research in protein biochemistry.
Related Products
Browse more in Peptides.



![[Lys(Me3)12]-Histone H4(1-21)-GGK(Biotin) - 1 mg](https://anaspecstore.com/wp-content/uploads/2026/10/as-64979-1-img-en-as-64979-1-01.jpg)
Reviews
There are no reviews yet.